2023
DOI: 10.1016/j.arr.2023.102132
|View full text |Cite
|
Sign up to set email alerts
|

Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to slow aging

Thomas Brochard,
Rebecca L. McIntyre,
Riekelt H. Houtkooper
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 93 publications
0
1
0
Order By: Relevance
“…Moreover, reverse transcriptase inhibitors reduced the amount of cytosolic DNA in old WT HSCs, rescuing their fitness compared with old Tet2 -deficient HSCs in vitro, although whether this approach can abrogate Tet2 -deficient HSPC expansion in vivo is unknown ( 83 ). Notably, others have suggested implementing reverse transcriptase inhibitors as rejuvenating treatments to correct aberrant expression of repetitive elements as well ( 148 ).…”
Section: Aging: the End Or Beginning Of The Odyssey?mentioning
confidence: 99%
“…Moreover, reverse transcriptase inhibitors reduced the amount of cytosolic DNA in old WT HSCs, rescuing their fitness compared with old Tet2 -deficient HSCs in vitro, although whether this approach can abrogate Tet2 -deficient HSPC expansion in vivo is unknown ( 83 ). Notably, others have suggested implementing reverse transcriptase inhibitors as rejuvenating treatments to correct aberrant expression of repetitive elements as well ( 148 ).…”
Section: Aging: the End Or Beginning Of The Odyssey?mentioning
confidence: 99%